Pharmaprojects lets researchers track the progress of drugs from bench to patient by exploring drug development by global and country development status, and therapeutic class status.
This database covers the progress of new drug candidates as they enter commercial pharmaceutical research and development programs, and tracks their progress from early preclinical development up to market launch, or to discontinuation if a drug fails at any stage.
Researchers can search drugs by chemical structure and other chemical attributes such as molecular weight or logP, or search by biological targets of the drugs. Besides searching the database, users can export data and set up alerts.
Click on the link above to register and create your account using your @yale.edu email.